Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls
Completed · Phase 1
Conditions studied: Parkinson Disease, Alzheimer Disease
In brief
The underlying goal of this study is to assess \[18F\] CFPyPB PET imaging as a tool to evaluate the activity of the GlyT1 receptors in the brain of Parkinson's Disease (PD) and Alzheimer Disease (AD) research participants.
Key facts
- Study ID
- NCT01461109
- Run by
- Institute for Neurodegenerative Disorders
- People needed
- 4
- Starts
- 2011-08-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2014-06-04
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.
Where it is running
- Institute_Neurodegenerative_Disorders — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.